Black Rock Inc. Gsk PLC Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$16.13 - $44.61 $19.1 Million - $52.9 Million	-1,185,225 Closed	0 $0
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $2.84 Million - $3.23 Million	67,594 Added 6.05%	1,185,225 $51.6 Million
Q1 2022 May 12, 2022	SELL	$40.23 - $47.74 $326,667 - $387,648	-8,120 Reduced 0.72%	1,117,631 $48.7 Million
Q4 2021 Feb 10, 2022	BUY	$38.88 - $45.31 $4.9 Million - $5.71 Million	125,981 Added 12.6%	1,125,751 $49.6 Million
Q3 2021 Nov 09, 2021	BUY	$38.79 - $43.16 $3.06 Million - $3.4 Million	78,892 Added 8.57%	999,770 $38.2 Million
Q2 2021 Aug 11, 2021	BUY	$36.52 - $41.46 $33.6 Million - $38.2 Million	920,878 New	920,878 $36.7 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.2B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.